About the Authors |
|
xi | |
Preface |
|
xiii | |
ICONS for The Sourcebook for Clinical Research: A Practical Guide for Study Conduct |
|
xv | |
|
Chapter 1 Foundational Elements and Regulatory Requirements |
|
|
1 | (30) |
|
1.1 What is the Purpose of Medical Research? |
|
|
1 | (1) |
|
1.2 Defining the Types of Research Studies |
|
|
2 | (8) |
|
1.3 Mandatory Regulations and ICH GCP (International Council for Harmonisation Good Clinical Practice) Ethical Guidelines |
|
|
10 | (6) |
|
1.4 How to Secure a Clinical Trial and How to Market Your Medical Facility to Sponsors |
|
|
16 | (2) |
|
1.5 Principal Investigator (PI) Responsibilities |
|
|
18 | (6) |
|
1.6 Research Coordinator (RC) Responsibilities |
|
|
24 | (2) |
|
1.7 Understanding the Role of HIPAA and PHI in Clinical Research |
|
|
26 | (5) |
|
|
28 | (3) |
|
Chapter 2 Preparation Before a Clinical Trial Begins |
|
|
31 | (58) |
|
2.1 Clinical Trial Feasibility Analysis |
|
|
31 | (1) |
|
2.2 Financial Conflict of Interest Regulations in a Clinical Trial |
|
|
32 | (3) |
|
2.3 Confidentiality Disclosure Agreement (Also Known as a Non-Disclosure Agreement) |
|
|
35 | (1) |
|
2.4 The Clinical Trial Contract (Also Known as a Clinical Services Agreement/CSA or a Clinical Trial Agreement/CTA) |
|
|
36 | (3) |
|
2.5 Consent Forms and Documentation |
|
|
39 | (23) |
|
2.5.1 Waiver or Alteration of Consent |
|
|
55 | (2) |
|
2.5.2 Waiver of Documentation of Consent |
|
|
57 | (1) |
|
|
58 | (2) |
|
|
60 | (2) |
|
2.6 The Clinical Trial Budget |
|
|
62 | (8) |
|
2.7 Study Start-Up and Sponsor Documentation Requirements |
|
|
70 | (1) |
|
2.8 The Medicare Coverage Analysis |
|
|
71 | (9) |
|
2.9 How to Register a Clinical Trial at www.ClinicalTrials.gov |
|
|
80 | (5) |
|
2.10 Flowchart for Sequence/Timing of All Tasks in This Chapter |
|
|
85 | (4) |
|
|
87 | (2) |
|
Chapter 3 Recruiting Clinical Research Subjects |
|
|
89 | (14) |
|
3.1 Activities Preparatory to Research: Identifying and/or Contacting Subjects for Study Recruitment |
|
|
89 | (3) |
|
3.2 Introduction to Recruiting Subjects for a Clinical Study |
|
|
92 | (2) |
|
3.2.1 Methods for Recruiting Subjects Internally |
|
|
93 | (1) |
|
3.3 Methods for Recruiting Subjects Externally |
|
|
94 | (2) |
|
3.4 External Subject Recruiting Strategies Involving Direct Media |
|
|
96 | (4) |
|
3.5 FDA Guidance Governing Direct Advertising |
|
|
100 | (3) |
|
|
101 | (2) |
|
Chapter 4 Clinical Trial Conduct--A Daily Perspective |
|
|
103 | (38) |
|
4.1 HIPAA (Health Insurance Portability and Accountability Act) and De-Identified Chart Reviews and Databases |
|
|
103 | (3) |
|
4.2 Translation and Interpretation |
|
|
106 | (3) |
|
4.3 Blinding and Unblinding in a Clinical Trial |
|
|
109 | (2) |
|
4.4 Adverse Events and Reporting in a Clinical Trial |
|
|
111 | (4) |
|
4.5 The Various Forms Used in a Clinical Trial |
|
|
115 | (16) |
|
4.5.1 Delegation of Authority (DOA)/Delegation of Responsibility |
|
|
129 | (2) |
|
4.6 Project Management for Clinical Trials |
|
|
131 | (4) |
|
4.7 Coding for Clinical Trial Claims |
|
|
135 | (3) |
|
|
138 | (3) |
|
|
139 | (2) |
|
Chapter 5 Organizations With Oversight Responsibility in Clinical Research |
|
|
141 | (12) |
|
5.1 The Institutional Review Board |
|
|
141 | (1) |
|
5.2 The Central Institutional Review Board |
|
|
142 | (1) |
|
5.3 Data Safety Monitoring Board, Also Known as the Data Monitoring Committee |
|
|
143 | (1) |
|
5.4 Clinical Endpoint Committee |
|
|
144 | (1) |
|
5.5 Association for the Accreditation of Human Research Protection Programs, Inc |
|
|
144 | (1) |
|
5.6 What You Need to Know About FDA Inspections, Compliance, & Enforcement |
|
|
144 | (9) |
|
|
152 | (1) |
|
Chapter 6 Exceptional Circumstances in Clinical Research |
|
|
153 | (38) |
|
6.1 Expanded Access (Compassionate Use) |
|
|
153 | (4) |
|
6.2 Charging for an Investigational New Drug in a Clinical Trial |
|
|
157 | (3) |
|
6.3 Emergency Use of a Test Article |
|
|
160 | (4) |
|
6.4 Research on Decedents and PHI in Clinical Research |
|
|
164 | (1) |
|
6.5 Vulnerable Populations |
|
|
165 | (4) |
|
6.6 Legally Authorized Representative and Witness |
|
|
169 | (9) |
|
6.7 What to do When a PI Departs From a Study or Institution |
|
|
178 | (6) |
|
6.8 Consequences of Clinical Research Non-Compliance and How to Respond to Non-Compliance |
|
|
184 | (7) |
|
|
189 | (2) |
|
Chapter 7 Education and Certification in Clinical Research |
|
|
191 | (10) |
|
7.1 Bachelors and Masters Degree Programs in Clinical Research |
|
|
191 | (5) |
|
7.2 Certification Organizations |
|
|
196 | (1) |
|
7.3 Training Requirements for Personnel Conducting Clinical Trials |
|
|
197 | (4) |
|
Chapter 8 The Newest Changes in Clinical Research |
|
|
201 | (26) |
|
8.1 Human Subjects Protection: Acceptance of Data From Clinical Investigations for Medical Devices |
|
|
201 | (1) |
|
|
202 | (7) |
|
8.3 Payment and Reimbursement to Research Subjects |
|
|
209 | (1) |
|
8.4 The Single Institutional Review Board (sIRB) |
|
|
209 | (2) |
|
8.5 New Changes to Certificates of Confidentiality |
|
|
211 | (2) |
|
8.6 New ICH GCP E6 R2 (Revision 2) Guidelines |
|
|
213 | (6) |
|
8.7 Electronic Common Technical Document (eCTD) |
|
|
219 | (1) |
|
8.8 New Changes in ClincialTrials.gov Registration and Reporting |
|
|
219 | (8) |
|
|
225 | (2) |
|
Chapter 9 After the Study Has Ended |
|
|
227 | (8) |
|
|
227 | (3) |
|
9.2 Essential Documents and Regulations for Document Retention in Clinical Research |
|
|
230 | (2) |
|
9.3 Publishing the Results of a Clinical Research Study |
|
|
232 | (3) |
|
|
234 | (1) |
Clinical Trials Glossary |
|
235 | (20) |
Index |
|
255 | |